Manuel Mendizabal

Summary

Affiliation: Universidad Austral
Country: Argentina

Publications

  1. ncbi request reprint Noncirrhotic portal hypertension: another cause of liver disease in HIV patients
    Manuel Mendizabal
    Department of Gastroenterology, University of Pennsylvania, Philadelphia, USA
    Ann Hepatol 8:390-5. 2009
  2. ncbi request reprint Post-transplant lymphoproliferative disorder in adult liver transplant recipients: a South American multicenter experience
    Manuel Mendizabal
    Hepatology and Liver Transplant Unit, Hospital Universitario Austral, Pilar, Buenos Aires, Argentina
    Clin Transplant 27:E469-77. 2013
  3. ncbi request reprint Liver transplantation in patients with cystic fibrosis: analysis of United Network for Organ Sharing data
    Manuel Mendizabal
    Unidad de Hígado y Trasplante Hepático, Hospital Universitario Austral, Pilar, Argentina
    Liver Transpl 17:243-50. 2011
  4. ncbi request reprint Neurological events after liver transplantation: a single-center experience
    Federico Piñero
    Hepatology and Liver Transplant Unit, Hospital Universitario Austral, Pilar, Provincia de Buenos Aires, Argentina
    Transpl Int 27:1244-52. 2014
  5. ncbi request reprint Changing etiologies and outcomes of acute liver failure: perspectives from 6 transplant centers in Argentina
    Manuel Mendizabal
    Hepatology and Liver Transplant Unit, Hospital Universitario Austral, Pilar, Argentina
    Liver Transpl 20:483-9. 2014
  6. ncbi request reprint Current management of hepatocellular carcinoma
    Manuel Mendizabal
    Servicio de Hepatologia, Trasplante Hepático y Cirugía Hepatobiliar, Hospital Universitario Austral, Pilar, Argentina
    Med Clin North Am 93:885-900, viii. 2009

Collaborators

Detail Information

Publications6

  1. ncbi request reprint Noncirrhotic portal hypertension: another cause of liver disease in HIV patients
    Manuel Mendizabal
    Department of Gastroenterology, University of Pennsylvania, Philadelphia, USA
    Ann Hepatol 8:390-5. 2009
    ..Prolonged exposure to ART, specially ddl, can play a pathogenic role. Rarely, liver synthetic function is sufficiently severe to warrant liver transplantation...
  2. ncbi request reprint Post-transplant lymphoproliferative disorder in adult liver transplant recipients: a South American multicenter experience
    Manuel Mendizabal
    Hepatology and Liver Transplant Unit, Hospital Universitario Austral, Pilar, Buenos Aires, Argentina
    Clin Transplant 27:E469-77. 2013
    ..66, p = 0.02), stage III/IV PTLD (HR 5.34, p = 0.004), and HCV infection (HR 7.68, p = 0.01). In conclusion, PTLD in OLT adult recipients is predominantly extranodal, and although mortality is high, long-term survival is possible...
  3. ncbi request reprint Liver transplantation in patients with cystic fibrosis: analysis of United Network for Organ Sharing data
    Manuel Mendizabal
    Unidad de Hígado y Trasplante Hepático, Hospital Universitario Austral, Pilar, Argentina
    Liver Transpl 17:243-50. 2011
    ..Despite such observations, a survival benefit was noted in transplant patients versus those who remained on the waiting list...
  4. ncbi request reprint Neurological events after liver transplantation: a single-center experience
    Federico Piñero
    Hepatology and Liver Transplant Unit, Hospital Universitario Austral, Pilar, Provincia de Buenos Aires, Argentina
    Transpl Int 27:1244-52. 2014
    ..0% as scores rose from 0 to 3, 4, 6-7 and 10 cumulative points, respectively. The score described helps to identify patients potentially at risk for neurologic events, and its prevention would decrease morbidity and mortality after LT. ..
  5. ncbi request reprint Changing etiologies and outcomes of acute liver failure: perspectives from 6 transplant centers in Argentina
    Manuel Mendizabal
    Hepatology and Liver Transplant Unit, Hospital Universitario Austral, Pilar, Argentina
    Liver Transpl 20:483-9. 2014
    ..A MELD score ≥ 29 and an encephalopathy grade ≥ 3 at admission were associated with death. The MELD score at admission showed the highest prognostic accuracy...
  6. ncbi request reprint Current management of hepatocellular carcinoma
    Manuel Mendizabal
    Servicio de Hepatologia, Trasplante Hepático y Cirugía Hepatobiliar, Hospital Universitario Austral, Pilar, Argentina
    Med Clin North Am 93:885-900, viii. 2009
    ..A multikinase inhibitor, sorafenib, is the first molecular targeted oral therapy that has recently been shown to provide a survival benefit in HCC in select patients...